1月22日，拓荆科技跌1.31%，成交额20.55亿元。两融数据显示，当日拓荆科技获融资买入额1.94亿 元，融资偿还1.86亿元，融资净买入796.99万元。截至1月22日，拓荆科技融资融券余额合计13.07亿 元。 融资方面，拓荆科技当日融资买入1.94亿元。当前融资余额12.92亿元，占流通市值的1.26%，融资余额 超过近一年90%分位水平，处于高位。 资料显示，拓荆科技股份有限公司位于辽宁省沈阳市浑南区水家900号，成立日期2010年4月28日，上市 日期2022年4月20日，公司主营业务涉及高端半导体专用设备的研发、生产、销售和技术服务。主营业 务收入构成为：半导体专用设备96.47%，其他(补充)3.53%。 截至9月30日，拓荆科技股东户数2.52万，较上期增加78.46%；人均流通股11091股，较上期减少 43.97%。2025年1月-9月，拓荆科技实现营业收入42.20亿元，同比增长85.27%；归母净利润5.57亿元， 同比增长105.14%。 分红方面，拓荆科技A股上市后累计派现1.74亿元。 机构持仓方面，截止2025年9月30日，拓荆科技十大流通股东中，香港中央结算有限公司位居第 ...

Group 1: 莱普科技 (Lepu Technology) - Lepu Technology focuses on advanced precision laser technology and semiconductor innovation processes, primarily engaged in the R&D, production, and sales of high-end semiconductor equipment, along with related technical services [1] - The company's equipment has been successfully applied in cutting-edge applications such as advanced process 3D NAND Flash storage chips, advanced process DRAM storage chips, and SiC power chips [1] Group 2: 电建新能源 (China Electric Power Construction New Energy) - China Electric Power Construction New Energy specializes in the development, investment, operation, and management of wind and solar power projects within China, with a focus on expanding its wind and solar power business [2] - As of the end of the reporting period, the company has a total installed capacity of 21.2461 million kilowatts, including 9.8909 million kilowatts from wind power projects and 11.3552 million kilowatts from solar power projects [2] Group 3: 鞍石生物 (Anshi Biopharmaceutical) - Anshi Biopharmaceutical is an innovative biopharmaceutical company that has entered the commercialization stage, focusing on oncology and other diseases with significant unmet clinical needs [2] - The company has established a competitive and commercially viable multi-layered pipeline of innovative drugs targeting important tumor driver gene pathways such as MET, EGFR, and HER2 [2] Group 4: 泰诺麦博 (Tainuo Maibo) - Tainuo Maibo is an innovative biopharmaceutical company dedicated to blood product alternatives, with its core product, TNM002, being the first-in-class recombinant anti-tetanus toxin monoclonal antibody drug expected to be approved in China by February 2025 [3] - TNM002 has been recognized as a breakthrough therapy by China's CDE and included in the priority review process, marking a significant innovation in the field of infection prevention [3] - Another core product, TNM001, is a potential long-acting monoclonal antibody for RSV prevention in infants, currently undergoing Phase III clinical trials [3]

Core Viewpoint - Chengdu Leap Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, focusing on advanced precision laser technology and semiconductor innovation processes, with significant growth in revenue and net profit during the reporting period [1][9] Revenue and Profit Growth - The company demonstrated strong growth, with revenue increasing from 74.15 million yuan in 2022 to 281 million yuan in 2024, achieving a compound annual growth rate of 96.25% [2] - Net profit turned from a loss of 9.38 million yuan in 2022 to a profit of 54.91 million yuan in 2024, with a slight profit of 683,200 yuan in Q1 2025 [2] R&D Investment Analysis - R&D expenses increased during the reporting period, with amounts of 15.28 million yuan, 23.95 million yuan, 58.74 million yuan, and 10.50 million yuan respectively [2] - The proportion of R&D expenses to revenue showed significant volatility, with figures of 20.61%, 12.56%, 20.9%, and 28.66% [3] - A notable increase in R&D expenses in 2024 by 145.23% was driven by external validation services and fixed asset investments, raising concerns about the sustainability of core technology development [3] Profit Quality and Asset Efficiency - Despite rapid profit growth, the company exhibited weaknesses in profit quality and asset operational efficiency, with negative cash flow from operating activities in most periods except for 2024 [4] - The net cash flow in 2024 was primarily due to an increase in operating payables, indicating a weak ability to convert revenue into cash [4] Accounts Receivable and Inventory Management - Accounts receivable increased significantly, with balances of 40.73 million yuan, 50.57 million yuan, 118 million yuan, and 117 million yuan, reflecting a rising proportion of accounts receivable to revenue [5] - Inventory value rose from 90.44 million yuan in 2022 to 226 million yuan in Q1 2025, with an increasing provision for inventory impairment, indicating potential issues in inventory management [5] Expense Control and Compliance - Management expenses increased from 14.71 million yuan in 2022 to 28.09 million yuan in 2024, with fluctuations in the proportion of revenue [6] - The company has a history of non-compliant dividend distributions, which raises concerns about internal governance and financial accounting practices [7] Financial Structure and Debt Pressure - The company’s financial structure shows a significant increase in liabilities, with a debt ratio rising from 28.91% in 2023 to 49.12% in Q1 2025 [8] - The company faces increased financial risk due to a declining short-term solvency ratio and a heavy reliance on long-term debt [8] Overall Assessment - Leap Technology has achieved rapid revenue and profit growth in the high-end semiconductor equipment sector, but faces scrutiny regarding profitability quality, asset management efficiency, and financial compliance as it seeks to meet the listing requirements of the Sci-Tech Innovation Board [9]

Core Viewpoint -拓荆科技 has shown significant stock price appreciation and strong financial performance, indicating a robust growth trajectory in the semiconductor equipment sector [1][2]. Financial Performance - As of September 30, 2025,拓荆科技 reported a revenue of 4.22 billion yuan, representing a year-on-year growth of 85.27% [2]. - The net profit attributable to shareholders for the same period was 557 million yuan, reflecting a year-on-year increase of 105.14% [2]. - Since its A-share listing, the company has distributed a total of 174 million yuan in dividends [2]. Stock Market Activity - On November 11, 2025, the stock price of 拓荆科技 increased by 4.40%, reaching 352.90 yuan per share, with a trading volume of 508 million yuan [1]. - The stock has appreciated by 130.05% year-to-date, with a 15.78% increase over the last five trading days and a 42.50% increase over the last 20 days [1]. - The company has a total market capitalization of 99.22 billion yuan [1]. Shareholder Composition - As of September 30, 2025, the number of shareholders for 拓荆科技 increased to 25,200, a rise of 78.46% [2]. - The average number of circulating shares per shareholder decreased by 43.97% to 11,091 shares [2]. - Major institutional shareholders have seen a reduction in their holdings, with significant decreases noted among several ETFs [2]. Business Overview - 拓荆科技 specializes in the research, production, sales, and technical services of high-end semiconductor equipment, with 96.47% of its revenue derived from this core business [1]. - The company is classified under the electronic-semiconductor-semiconductor equipment sector and is involved in various concept sectors including buybacks and semiconductor equipment [1].

Core Insights - On November 4, Tuojing Technology's stock rose by 3.19%, with a trading volume of 2.878 billion yuan [1] - As of November 4, the total margin balance for Tuojing Technology was 1.145 billion yuan, indicating a high level of margin activity [1][2] - For the period from January to September 2025, Tuojing Technology reported a revenue of 4.22 billion yuan, representing a year-on-year growth of 85.27%, and a net profit of 557 million yuan, up 105.14% year-on-year [2] Financing and Margin Activity - On November 4, Tuojing Technology had a financing buy-in of 292 million yuan, with a net buy of 65.51 million yuan after repayments [1] - The current financing balance of 1.119 billion yuan accounts for 1.31% of the circulating market value, exceeding the 90th percentile of the past year [1] - In terms of securities lending, Tuojing Technology had a remaining short position of 83,100 shares, with a short balance of 25.318 million yuan, also at a high level [1] Shareholder and Institutional Holdings - As of September 30, the number of shareholders for Tuojing Technology increased by 78.46% to 25,200, while the average circulating shares per person decreased by 43.97% to 11,091 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 5.1205 million shares, a decrease of 1.7072 million shares from the previous period [2] - Other notable institutional shareholders include E Fund and Huaxia ETFs, all of which have seen a reduction in their holdings [2]

Core Viewpoint - Chengdu Leap Technology Co., Ltd. has entered the inquiry stage for its IPO on the Sci-Tech Innovation Board, aiming to raise approximately 850 million yuan for various projects and working capital [1] Company Overview - Leap Technology focuses on advanced precision laser technology and semiconductor innovation processes, primarily engaged in the R&D, production, and sales of high-end semiconductor equipment [1] IPO Details - The company’s IPO was accepted on September 29, 2025, and it plans to invest in several key projects, including the development and manufacturing center for wafer fabrication equipment, advanced packaging equipment, R&D center, and marketing network [1] - The total amount intended to be raised is around 850 million yuan, which will be allocated to projects based on urgency after deducting issuance-related expenses [1]

Core Viewpoint - The stock of Tuojing Technology has shown significant volatility, with a year-to-date increase of 60.74% but a recent decline of 8.07% over the past five trading days, indicating potential market fluctuations and investor sentiment shifts [1]. Company Overview - Tuojing Technology Co., Ltd. is based in Shenyang, Liaoning Province, and specializes in the research, production, sales, and technical services of high-end semiconductor equipment. The company was established on April 28, 2010, and went public on April 20, 2022 [1]. - The main revenue source for Tuojing Technology comes from semiconductor equipment, accounting for 96.47% of total revenue, with other supplementary services making up 3.53% [1]. Financial Performance - For the first half of 2025, Tuojing Technology reported a revenue of 1.954 billion yuan, reflecting a year-on-year growth of 54.25%. However, the net profit attributable to shareholders decreased by 26.96% to 94.288 million yuan [2]. - Since its A-share listing, Tuojing Technology has distributed a total of 174 million yuan in dividends [2]. Shareholder Structure - As of June 30, 2025, the number of shareholders for Tuojing Technology was 14,100, a decrease of 4.69% from the previous period. The average number of circulating shares per shareholder increased by 89.04% to 19,794 shares [2]. - The top ten circulating shareholders include notable entities such as the Huaxia SSE Sci-Tech Innovation Board 50 ETF and the Hong Kong Central Clearing Limited, with varying changes in their holdings [2].

Core Insights - On October 13, Tuojing Technology's stock rose by 1.22%, with a trading volume of 2.514 billion yuan [1] - The company reported a financing buy-in of 216 million yuan and a financing repayment of 224 million yuan on the same day, resulting in a net financing outflow of 8.6561 million yuan [1] - As of October 13, the total margin balance for Tuojing Technology was 1.011 billion yuan, indicating a high level of financing activity [1] Financing Summary - On October 13, Tuojing Technology had a financing buy-in of 216 million yuan, with a current financing balance of 994 million yuan, accounting for 1.32% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of securities lending, 2,397 shares were repaid while 2,500 shares were sold short, with a total short sale value of 670,600 yuan [1] Company Overview - Tuojing Technology, established on April 28, 2010, is located in Shenyang, Liaoning Province, and was listed on April 20, 2022 [1] - The company's main business involves the research, production, sales, and technical services of high-end semiconductor equipment, with 96.47% of its revenue coming from this segment [1] Financial Performance - As of June 30, the number of shareholders for Tuojing Technology was 14,100, a decrease of 4.69% from the previous period [2] - For the first half of 2025, the company achieved a revenue of 1.954 billion yuan, representing a year-on-year growth of 54.25%, while the net profit attributable to shareholders decreased by 26.96% to 94.288 million yuan [2] - The company has distributed a total of 174 million yuan in dividends since its A-share listing [2] Institutional Holdings - As of June 30, 2025, the fourth largest circulating shareholder of Tuojing Technology is the Huaxia SSE Sci-Tech Innovation Board 50 ETF, holding 7.7938 million shares, a decrease of 80,200 shares from the previous period [2] - The Hong Kong Central Clearing Limited is the fifth largest shareholder, increasing its holdings by 1.1926 million shares to 6.8277 million shares [2] - Other notable changes include the sixth largest shareholder, E Fund SSE Sci-Tech Innovation Board 50 ETF, increasing its holdings by 192,500 shares to 5.7902 million shares [2]

Core Insights - On October 9, Tuojing Technology's stock rose by 6.73%, with a trading volume of 3.04 billion yuan [1] - The company reported a financing buy-in of 272 million yuan and a financing repayment of 338 million yuan, resulting in a net financing outflow of 66.81 million yuan [1] - As of October 9, the total margin balance for Tuojing Technology was 1.031 billion yuan, indicating a high level of financing activity [1] Financing Summary - On October 9, Tuojing Technology had a financing buy-in of 272 million yuan, with a current financing balance of 1.014 billion yuan, accounting for 1.30% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of securities lending, the company repaid 11,000 shares and sold 600 shares, with a total selling amount of 166,600 yuan [1] Company Overview - Tuojing Technology, established on April 28, 2010, is located in Shenyang, Liaoning Province, and was listed on April 20, 2022 [1] - The company's main business involves the research, production, sales, and technical services of high-end semiconductor equipment, with 96.47% of its revenue coming from this segment [1] Financial Performance - As of June 30, the number of shareholders for Tuojing Technology was 14,100, a decrease of 4.69% from the previous period [2] - For the first half of 2025, the company achieved a revenue of 1.954 billion yuan, representing a year-on-year growth of 54.25%, while the net profit attributable to shareholders decreased by 26.96% to 94.288 million yuan [2] - The company has distributed a total of 174 million yuan in dividends since its A-share listing [2] Institutional Holdings - As of June 30, 2025, the fourth largest circulating shareholder is the Huaxia SSE Sci-Tech Innovation Board 50 ETF, holding 7.7938 million shares, a decrease of 80,200 shares from the previous period [2] - The Hong Kong Central Clearing Limited increased its holdings to 6.8277 million shares, an increase of 1.1926 million shares [2] - Other notable changes include an increase in holdings by the E Fund SSE Sci-Tech Innovation Board 50 ETF and a decrease by the Noan Growth Mixed A fund [2]

Core Viewpoint - Chengdu Leap Technology Co., Ltd. has received acceptance for its IPO on the Sci-Tech Innovation Board, focusing on advanced precision laser technology and semiconductor innovation processes [1] Company Overview - Leap Technology specializes in the research, development, production, and sales of high-end semiconductor equipment, along with providing related technical services [1] IPO Details - The company aims to raise approximately 850 million yuan, which will be allocated to various projects including the development and manufacturing center for wafer manufacturing equipment, advanced packaging equipment, R&D center, information technology construction, and working capital [1]